Anal cancer screening in HIV-infected patients: Is it time to screen them all?

Alexander O. Mallari, Theresa M. Schwartz, Amneris E. Luque, Pamela S. Polashenski, Stephen M. Rauh, Roberto B. Corales

Research output: Contribution to journalReview articlepeer-review

15 Scopus citations

Abstract

BACKGROUND: Annual screening for anal cancer is recommended only for HIV patients at increased risk: men who have sex with men, individuals with a history of anogenital warts, and women with cervical dysplasia. OBJECTIVE: The aim of this study was to examine the screening outcomes between HIV populations with and without these risk factors. METHODS: We reviewed the records of all HIV patients referred for anal cytology and high-resolution anoscopy from June 2009 to June 2010. Patients were stratified into an increased-risk group or a standard-risk group. MAIN OUTCOME: Of the 329 evaluable patients, 285 (89.8% men, 10.2% women, mean age 46 ± 10 years) were classified to the increased-risk group, whereas 44 (72.7% men, 27.3% women, mean age 52 ± 8 years) were included in the standard-risk group. Male sex, white race, sexual orientation, past and current receptive anal intercourse, noncompliance with condom use, and absence of a new sexual partner were significantly different in the increased-risk group in comparison with the standard-risk group. In the increased-risk group, 187 (66.5%) patients had biopsy-proven dysplasia of which 118 (42.0%) had high-grade disease. In the standard-risk group, 15 (34.9%) patients had biopsy-proven dysplasia of which 7 (16.3%) had high-grade disease. Cytology detected biopsy-confirmed high-grade dysplasia only in 23 of 118 (19.5%) patients in the increased-risk group and in 2 of 7 (28.6%) patients in the standard-risk group. Kappa agreement in detecting high-grade disease was low for both increased-risk and standard-risk groups: 0.16 (95% CI 0.07-0.23) and 0.40 (95% CI 0.02-0.40). LIMITATIONS: Our study is a chart-based retrospective review of data with a small female population. Histology reports came from 2 different laboratories. CONCLUSION: High-grade anal dysplasia was prevalent even among HIV patients who only have standard risk factors. Anal cytology and high-resolution anoscopy have poor agreement. We suggest considering annual screening by using high-resolution anoscopy in addition to cytology for all HIV patients regardless of risk factors.

Original languageEnglish (US)
Pages (from-to)1244-1250
Number of pages7
JournalDiseases of the Colon and Rectum
Volume55
Issue number12
DOIs
StatePublished - Dec 1 2012

Keywords

  • Anal cancer
  • Anoscopy
  • Cytology
  • Dysplasia
  • HIV
  • Screening

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Anal cancer screening in HIV-infected patients: Is it time to screen them all?'. Together they form a unique fingerprint.

Cite this